Navrogen Closes $3.0M Seed Financing To Advance Its Preclinical Pipeline Targeting Humoral Immunosuppressed Cancers And Immune-Related Disorders
Amount Raised
$3 Million
Round Type
Seed
CheyneyBiotechnologyDescription
Navrogen, Inc., a privately held preclinical biotechnology company, announced today that it has raised $3.0M from an equity financing to support its Humoral Immuno-Oncology (HIO) discovery platform and preclinical therapeutic pipeline activities. HIO is a process by which tumors produce factors that suppress a patient's humoral immune response against malignant tissues. The major use of proceeds will focus on advancing the company's lead HIO-refractory, anti-mesothelin NAV-001 antibody drug conjugate program and its NK cell activator platforms that specifically address HIO suppressed cancers and immune-mediated diseases. The financing was led by Tellus BioVentures along with existing investors
Quick answer
Navrogen, Inc. raised $3 Million in a Seed round, dated August 9, 2021. Navrogen, Inc. is based in Cheyney, Pennsylvania, United States.
- How much did Navrogen, Inc. raise?
- Navrogen, Inc. raised $3 Million in a Seed round on August 9, 2021.
- What does Navrogen, Inc. do?
- Navrogen Inc. is a biopharmaceutical company focused on the targeted treatment of cancer.
- Where is Navrogen, Inc. based and how big is it?
- Navrogen, Inc. is based in Cheyney, Pennsylvania, United States.
- Who are the decision-makers at Navrogen, Inc?
- Fundz holds 1 contact at Navrogen, Inc., including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Navrogen, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Opentrons Labworks raised $209M on September 23, 2021.
- PhenoBiome raised an undisclosed amount (Funding Round) on September 23, 2021.
- Opentrons Labworks raised $200M (Series C) on September 23, 2021.
- Garuda Therapeutics raised $72M (Series A) on September 23, 2021.
- GenEdit raised an undisclosed amount (Series A) on September 23, 2021.
- Nusano raised $48M on September 23, 2021.
Who to call at Navrogen, Inc., and when
A new round usually means Navrogen, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Navrogen, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Navrogen, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Navrogen, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Navrogen, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Navrogen, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.